Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for decades, carbohydrate chemistry has eluded researchers because of the complexity of the molecules and the difficulty of working with them. Synthon is the first and only company to unlock the rich source of chirality contained in naturally occurring carbohydrates. The company uses its proprietary technology to economically construct the most challenging chiral molecules, which serve as cores for drugs being developed in the fastest